Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
N.D. Prolisok is a Ukrainian biotechnology company specializing in the development and production of advanced multiprobiotics under the brand name Symbiter. Founded on extensive research into human microbiota, the company focuses on creating concentrated microbial compositions that restore physiological balance and support the immune system. Their product line includes specialized formulations for infants, children, and adults, targeting conditions such as dysbiosis, gastrointestinal infections, and allergic disorders. N.D. Prolisok operates its own research and manufacturing facilities in Kyiv, maintaining a strong emphasis on clinical validation and scientific collaboration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on N.D. Prolisok.